Diabetic kidney disease, a common complication in patients with type 2 diabetes mellitus, is associated with a markedly increased morbidity and mortality, especially of cardiovascular origin, and faster progression to end-stage renal disease
The medications safety profile primarily includes gastrointestinal symptoms such as nausea, constipation, diarrhea, and decreased appetite
What happens if I miss a Brello injection
There are a few reasons why: Alcohol adds calories without much fullness or nutrition
Comparative effectiveness of tirzepatide and semaglutide for obesity management in US clinical practice: a 6-month retrospective cohort study
The Linagliptin CVOTs In the Cardiovascular and Renal Microvascular Outcome Study With Linagliptin (CARMELINA), 6,979 patients with type 2 diabetes and high risk of cardiovascular and kidney events were randomized to linagliptin och placebo for a median follow-up of 2.2 years